🟢 Nasus Pharma is trading 5.8% up in after-hours trading with no identified company-specific catalyst

Nasus Pharma is trading 5.8% higher in after-hours trading at $3.65, versus its October 9 regular-session close of $3.51; no clear company-specific announcement explaining the move was found for October 9.

• Shares had declined across the prior five sessions.
• The latest identified company news was the September 29 announcement that the first patient was dosed in its NS003 Phase 1 study, before this move.
• Broad-market context was positive but does not establish the cause of this individual move.